A prospective comparison of three ultrasound-based techniques in quantitative diagnosis of hepatic steatosis in NAFLD

[1] Tamaki N(2022)Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD Nature Reviews Endocrinology 18 55-66

[2] Ajmera V(2021)Quantification of liver fat content with ultrasound: a WFUMB position paper Ultrasound Med Biol 47 2803-2820

[3] Loomba R(2022)New horizon of ultrasound for screening and surveillance of non-alcoholic fatty liver disease spectrum Eur J Radiol 154 389-398

[4] Ferraioli G(2019)Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis Lancet Gastroenterol Hepatol 4 11-20

[5] Berzigotti A(2018)Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention Nat Rev Gastroenterol Hepatol 15 1322-1332

[6] Barr RG(2020)Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials Journal of hepatology 73 549-562

[7] Guan X(2019)Ultrasound of diffuse liver disease including elastography Radiol Clin North Am 57 1047-1054

[8] Chen YC(1999)Ultrasound backscatter and attenuation in human liver with diffuse disease Ultrasound in Medicine & Biology 25 419-428

[9] Xu HX(2015)Effects of fatty infiltration in human livers on the backscattered statistics of ultrasound imaging Proc Inst Mech Eng H 229 1348-1359

[10] Li J(2018)Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis Hepatology 67 576-581

[1] Tamaki N(2022)Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD Nature Reviews Endocrinology 18 55-66

[2] Ajmera V(2021)Quantification of liver fat content with ultrasound: a WFUMB position paper Ultrasound Med Biol 47 2803-2820

[3] Loomba R(2022)New horizon of ultrasound for screening and surveillance of non-alcoholic fatty liver disease spectrum Eur J Radiol 154 389-398

[4] Ferraioli G(2019)Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis Lancet Gastroenterol Hepatol 4 11-20

[5] Berzigotti A(2018)Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention Nat Rev Gastroenterol Hepatol 15 1322-1332

[6] Barr RG(2020)Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials Journal of hepatology 73 549-562

[7] Guan X(2019)Ultrasound of diffuse liver disease including elastography Radiol Clin North Am 57 1047-1054

[8] Chen YC(1999)Ultrasound backscatter and attenuation in human liver with diffuse disease Ultrasound in Medicine & Biology 25 419-428

[9] Xu HX(2015)Effects of fatty infiltration in human livers on the backscattered statistics of ultrasound imaging Proc Inst Mech Eng H 229 1348-1359

[10] Li J(2018)Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis Hepatology 67 576-581